We are:

• A Biotechnology Company Specializing in Human Vaccines
• Creating, Developing, Manufacturing & Testing Innovative AIDS Vaccines
• Conducting Multiple Site Phase 2 Human Clinical Vaccine Trial

Our AIDS Vaccines:

• Are Designed for Predominant AIDS Virus Subtypes
• Use DNA & Viral Vector Technologies
• Satisfactorily Completed Phase 1 Human Clinical Trial Testing
• Have Been Proven Safe & Have Demonstrated Ability To Stimulate Immune Responses

Key Market Factors:

• Vaccines Are The Most Cost Effective Way to Combat Infectious Disease
• Large Global AIDS Vaccine Market Is Estimated To Be More Than $4 Billion
• Customer Base Includes All Ages, Gendors, Races, Nationalities, Geographical Regions